XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid in Capital
Cumulative Net Income
Accumulated Other Comprehensive Income
Cumulative Dividends
Beginning balance (in shares) at Dec. 31, 2022   0          
Beginning balance at Dec. 31, 2022 $ 496,814 $ 0 $ 259 $ 625,136 $ 81,142 $ 22,667 $ (232,390)
Balance, beginning of period (in shares) at Dec. 31, 2022 25,897,000   25,897,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock, net of issuance costs (in shares)     249,000        
Issuance of common stock, net of issuance costs $ 8,906   $ 3 8,903      
Stock-based compensation, net of forfeitures (in shares)     128,000        
Stock-based compensation, net of forfeitures 14,346   $ 1 14,345      
Increase in fair value of cash flow hedges (4,973)         (4,973)  
Reclassification for amounts recognized as interest expense (2,010)         (2,010)  
Net income (loss) (6,922)       (6,922)    
Dividends to common stockholders (11,646)           (11,646)
Ending balance (in shares) at Mar. 31, 2023   0          
Ending balance at Mar. 31, 2023 494,515 $ 0 $ 263 648,384 74,220 15,684 (244,036)
Balance, end of period (in shares) at Mar. 31, 2023     26,274,000        
Beginning balance (in shares) at Dec. 31, 2022   0          
Beginning balance at Dec. 31, 2022 $ 496,814 $ 0 $ 259 625,136 81,142 22,667 (232,390)
Balance, beginning of period (in shares) at Dec. 31, 2022 25,897,000   25,897,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock, net of issuance costs (in shares) 1,385,000            
Ending balance (in shares) at Dec. 31, 2023 0 0          
Ending balance at Dec. 31, 2023 $ 513,256 $ 0 $ 276 688,156 88,856 16,417 (280,449)
Balance, end of period (in shares) at Dec. 31, 2023 27,613,000   27,613,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock, net of issuance costs (in shares) 19,000   19,000        
Issuance of common stock, net of issuance costs $ 463   $ 0 463      
Stock-based compensation, net of forfeitures (in shares)     90,000        
Stock-based compensation, net of forfeitures 2,424   $ 1 2,423      
Shares withheld on vesting of stock-based compensation (in shares)     (21,000)        
Shares withheld on vesting of stock-based compensation (551)     (551)      
Increase in fair value of cash flow hedges 7,870         7,870  
Reclassification for amounts recognized as interest expense (2,797)         (2,797)  
Net income (loss) 3,665       3,665    
Dividends to common stockholders $ (12,684)           (12,684)
Ending balance (in shares) at Mar. 31, 2024 0 0          
Ending balance at Mar. 31, 2024 $ 511,646 $ 0 $ 277 $ 690,491 $ 92,521 $ 21,490 $ (293,133)
Balance, end of period (in shares) at Mar. 31, 2024 27,701,000   27,701,000